Helix BioPharma Corp (HBP)
TSX
The current HBP market cap is 47.55M. The company's latest EPS is CAD -0.1890 and P/E is -5.13.
Year End July 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -8.62M | -9.13M | -5.87M | -6.22M | -9.01M |
Net Income | -9.17M | -8.04M | -6.56M | -6.29M | -9.26M |
Year End July 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 4.91M | 4.07M | 3.73M | 1.03M | 1.49M |
Total Liabilities | 1.93M | 5.46M | 3.41M | 1.87M | 1.58M |
Total Equity | 2.98M | -1.39M | 319k | -844k | -90k |
Year End July 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -10.83M | -9.3M | -6.51M | -5.53M | -5.22M |
Investing | 1.7M | 2.02M | N/A | -5k | -14k |
Financing | 13.1M | 6.56M | 6.21M | 3.09M | 5.51M |
Market Cap | 47.55M |
Price to Earnings Ratio | -5.13 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 43.89 |
Price to Book Ratio | -528.35 |
Dividend Yield | - |
Shares Outstanding | 49.02M |
Average Volume (1 week) | 833 |
Average Volume (1 Month) | 7.97k |
52 Week Change | -7.62% |
52 Week High | 1.35 |
52 Week Low | 0.50 |
Spread (Intraday) | 0.07 (7%) |
Company Name | Helix BioPharma Corp |
Address |
2704, 401 bay street toronto, ontario M5H 2Y4 |
Website | https://www.helixbiopharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.